MGX: Total Utang marang Modal Metagenomi, Inc

Logo korporat perusahaan Metagenomi Inc. (MGX)

Metagenomi, Inc. (MGX) delegates laboratory research and drug production to external contractors, maintaining a critical dependence on partner capacities. This chart of the current share price reflects a total debt-to-equity ratio of 0.36. High authority among scientists and support from pharma behemoths enable the company to develop precision genome editing for the therapy of severe pathologies.

metagenomi.co (MGX): Rasio Total Utang marang Ekuitas saka 21.02.2024 nganti 31.10.2026

Rincian metrik keuangan lan pasar Metagenomi Therapeutics (MGX)

- rega lan prakiraan konsensus rega:
Bagan rega Metagenomi|MGX - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Kapitalisasi pasar Metagenomi|MGX - Nilai Perusahaan
- indikator kapitalisasi buku:
Aset Bersih saben Siji Saham Metagenomi|MGX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku metagenomi.co|MGX - Aset Perusahaan
- rincian utang lan likuiditas:
Rasio Total Utang marang Ekuitas Metagenomi, Inc.|MGX - Rasio silihan jangka dawa marang modal|Utang jangka cendhak marang modal Metagenomi, Inc.|MGX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Metagenomi|MGX - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Metagenomi|Likuiditas cepet metagenomi.co
- data bathi resik lan rasio valuasi:
MGX - Bathi perusahaan
Analisis dhasar perusahaan:Metagenomi, MGX
Produk merek Metagenomi Therapeutics

For investors in the high-tech sector, Metagenomi, Inc. (MGX) is an attractive player in the capital-intensive gene editing niche. This metric measures the proportion of borrowed funds relative to equity, and analyzing the debt-to-equity ratio allows for an assessment of the company's financial stability amidst colossal expenditures on CRISPR patents and regulatory requirements, thereby minimizing default risk.

Pesaing Metagenomi, Inc. (MGX)

Utang marang Ekuitas tempus.com|Rasio Utang marang Ekuitas QGEN (Qiagen NV)|Total Utang marang Modal IONS|Total Utang marang Modal Repligen Inc. (RGEN)|Utang marang Ekuitas Avidity Biosciences RNA|CRSP - Rasio Total Utang marang Ekuitas|GeneDx - Total Utang marang Modal|Utang marang Modal Ultragenyx Pharmaceutical Inc.|BEAM (Beam Therapeutics Corp) - Rasio Total Utang marang Ekuitas|SRPT: Utang Agregat marang Modal|TWST (Twist Bioscience) - Total Utang marang Modal|Total Utang marang Modal 10xgenomics.com|Total Utang marang Modal NTLA|Stoke Therapeutics Inc (STOK) - Rasio Utang marang Modal|Total Utang marang Modal BLFS (BioLife Corp)|Wave Pharma (WVE) - Utang marang Modal|MAZE - Utang marang Ekuitas|SION (sionnatx.com) - Rasio Utang marang Ekuitas|Prime Medicine (PRME) - Utang marang Ekuitas|Utang marang Modal Taysha Gene Therapies Inc (TSHA)|Utang marang Ekuitas uniQure Corp|Rasio Total Utang marang Ekuitas MeiraGTx Corp (MGTX)|Total Utang marang Modal RGNX|Koefisien Total Utang marang Modal solidbio.com|Ocugen - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PACB|Benitec - Total Utang marang Modal|Koefisien Total Utang marang Modal Design Corp DSGN|Rocket Pharmaceuticals (RCKT) - Utang marang Ekuitas|Rasio Utang marang Ekuitas FDMT|LXEO (Lexeo Therapeutics Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas Korro Bio, Inc (KRRO)|Rasio Total Utang marang Ekuitas EDIT (Editas)|Koefisien Total Utang marang Modal Silence Therapeutics Corp|Utang marang Ekuitas ProQR Therapeutics PRQR|CDXS - Rasio Total Utang marang Ekuitas|Sangamo Therapeutics, Inc. - Total Utang marang Modal|Rasio Utang marang Modal Nautilus Biotechnology (NAUT)|DTIL (Precision BioSciences, Inc.) - Rasio Total Utang marang Ekuitas|Rasio Utang marang Ekuitas GBIO|BOLD (Boundless Bio, Inc.) - Total Utang marang Modal|Rasio Utang marang Ekuitas XCUR (Exicure Corp)|Utang marang Ekuitas Imunon, Inc. (IMNN)|phiopharma.com - Rasio Utang marang Ekuitas|Total Utang marang Modal MBIO (Mustang Bio)|Total Utang marang Modal TransCode Therapeutics Inc. RNAZ|BNGO - Utang marang Ekuitas|adnas.com (APDN) - Rasio Total Utang marang Ekuitas|BLUE: Total Utang marang Modal|Utang marang Modal ImmunoPrecise Antibodies Ltd. (IPA)|Rasio Total Utang marang Ekuitas OMGA|OMIC (Singular Genomics Corp) - Utang Agregat marang Modal|Total Utang marang Modal RGLS|Total Utang marang Modal syros.com (SYRS)|Total Utang marang Modal TBIO (Telesis Bio)|Rasio Utang marang Modal TRACON Pharmaceuticals Inc.|Unity Bio - Total Utang marang Modal